Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 556 5233
Email
margaret.ryan@otago.ac.nz
Position
Senior Research Fellow
Department
Department of Anatomy
Qualifications
BSc (Hons) PhD
Research summary
Memory and Alzheimer's disease

Research

Memory loss arising from neurodegenerative diseases such as Alzheimer's disease is devastating both to the individual and to their loved ones, robbing the individual of many of his/her uniquely identifiable characteristics. Dr Ryan's interest is in how memories are formed and stored in the brain at the molecular level and how this may be altered in Alzheimer's disease.

Publications

Cawood, S. M. F., Williams, J. M., Ryan, M. M., Harrison, O. K., & Russell, B. R. (2024, August-September). Preliminary findings that Ketamine increases GABA levels in the amygdala two hours post infusion in people with treatment resistant anxiety. Verbal presentation at the Queenstown Research Week (QRW) Mental Health Meeting, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Cawood, S. M. F., Russell, B. R., Harrison, O. K., Williams, J. M., & Ryan, M. M. (2024). Plasma-derived microRNAs are altered with ketamine intervention for treatment-resistant generalised or social anxiety disorders. In K.-L. Horne (Ed.), Proceedings of the 40th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 63). Retrieved from https://www.awcbr.org Conference Contribution - Published proceedings: Abstract

Cawood, S., Williams, J., Ryan, M., Russell, B., & Harrison, O. (2023, August). The neurobiology of anxiety, depression, and breathing-related catastrophising. Poster session presented at the Brain Health Research Centre (BHRC) Annual Conference, Dunedin, New Zealand. Conference Contribution - Poster Presentation (not in published proceedings)

Mockett, B. G., & Ryan, M. M. (2023). The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer’s disease and related neurological disorders. Seminars in Cell & Developmental Biology, 139, 93-101. doi: 10.1016/j.semcdb.2022.05.014 Journal - Research Other

Cawood, S., Neehoff, S., Glue, P., Williams, J., Ryan, M., Russell, B., & Harrison, O. (2022). Investigating the relationship between microRNA expression, brain structure and biochemistry in anxiety disorders and their potential treatment with ketamine. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 82). Retrieved from https://www.queenstownresearchweek.org Conference Contribution - Published proceedings: Abstract

Back to top